Effects of Prebiotic-based Snacks on the Gut Microbiota and Perceived 'Satisfaction' (NutriSAT)
Investigating the Effects of Prebiotic-based Snacks on Perceived Feelings of 'Satisfaction' and on the Balance of Bacteria in the Human Gut (NutriSAT)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Berkshire
-
Reading, Berkshire, United Kingdom, RG6 6AP
- University of Reading
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria -
- Aged between 22 and 55 years
- Healthy (no medical conditions in the last 12 months)
- BMI between 22.0 and 27.9 kg/m2
- Non-smokers
- Not a vegetarian or vegan
- No antibiotics in the last 6 months
- Not donated more than 350 ml blood in 4 months prior to or following study
Exclusion Criteria -
- Had surgery or suffered a medical condition affecting the circulatory, nervous or digestive systems in the previous 12 months
- Had suffered a myocardial infarction or stroke in the previous 12 months
- Suffer from any blood-clotting disorder or prescription of any medication affecting blood clotting
- Suffer from any metabolic disorders (e.g. diabetes, metabolic syndrome or hypertension)
- Any requirement to take long-term medication, especially those active on the gastro-intestinal tract or for cardio-vascular disease [including proton pump inhibitors (e.g. Omeprazole, Esomeprazole, Lansoprazole or Pantoprazole), non-steroidal anti-inflammatory drugs (e.g. acetylsalicylic acid, ibuprofen or diclofenac) or anti-anxiety medication (e.g. benzodiazepine)]
- Use of antibiotics within the previous 6 months
- Any dietary restrictions or on a weight reducing diet
- Irregular eating patterns and those not consuming breakfast
- Any food allergies (e.g. milk protein allergies) or intolerances (e.g. lactose)
- Use of medication which affects food intake or behaviour (e.g. anti-depressants)
- Use of medication likely to affect taste, smell or appetite
- Use of cholesterol lowering drugs/functional foods (e.g. Flora pro-activ)
- Dietary fibre consumption > 20 g/d
- Those that dislike the study foods and beverages
- Three Factor Eating Questionnaire (TFEQ) Factor 1 score >13
- Use of any vitamin supplements or fish oil capsules
- A history of alcohol or drug misuse (the average daily number of units of alcohol considered as acceptable is 2-3 units women; 3-4 units men)
- Smoking
- Athletes in training (> 8 h exercise/week)
- Amount of sleep each night (<5 hours/night)
- Females who are breast-feeding, may be pregnant, or if of child-bearing potential and are not using effective contraceptive precautions
- Involvement in a study involving an experimental drug/medication within 4 weeks prior to entry to the study
- History of chronic constipation or diarrhoea, or other chronic gastrointestinal complaint (e.g. irritable bowel syndrome)
- Intake of other supplementary prebiotics (such as oligosaccharides, e.g. FOS, GOS) or probiotics, drugs active on gastrointestinal motility such as antidiarrheals (e.g. medicines containing loperamide, bismuth subsalicyte or atropine/diphenoxylate), medication for abdominal pain and intestinal discomfort (e.g. duspatalin) or laxatives of any class (medications containing e.g. polyethylene glycol 3350, bisacodyl, methylcellulose or lactulose) during or within the four weeks prior to the start of the study
- Aged below 22 or over 55 years
- Have a Body Mass Index (BMI) of less than 22 or more than 27.9 kg/m2 [for volunteers of Asian origin; BMI of less than 21, or between to 23 to 25, or above 27 kg/m2].
- Blood pressure > 160/90 mmHg
- Vegan or vegetarian
- Donated > 350 ml of blood within the 4 months prior to the study or plan on donating > 350 ml of blood within the 4 months following the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
Maltodextrin
|
|
|
Experimental: Prebiotic
Nutriose FB06 14g/day
|
Wheat dextrin soluble fibre
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Differences in perceived appetite (assessed using visual analogue scales)
Time Frame: Within 18 months
|
Within 18 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Alterations to the relative balance of bacterial groups in faeces (assessed using flow cytometry)
Time Frame: Within 18 months
|
Within 18 months
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes to metabolite and gut hormones responses in plasma (measured using ELISA and other assays)
Time Frame: Within 18 months
|
Within 18 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Orla Kennedy, University of Reading
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- H5117800
- Ethics No. 11/08 (Other Identifier: University of Reading)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.